Diprivan is a Intravenous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by General Injectables & Vaccines, Inc. The primary component is Propofol.
| Product ID | 52584-269_bc7ce430-9a37-4654-b256-3a7ef0643e9b |
| NDC | 52584-269 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Diprivan |
| Generic Name | Diprivan |
| Dosage Form | Injection, Emulsion |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2010-03-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019627 |
| Labeler Name | General Injectables & Vaccines, Inc |
| Substance Name | PROPOFOL |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | General Anesthesia [PE],General Anesthetic [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Category | NDA |
| Application Number | NDA019627 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-03-01 |
| Marketing End Date | 2017-01-18 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| PROPOFOL | 10 mg/mL |
| SPL SET ID: | 7603f1ba-cfbd-4ec5-881a-13f4832c9893 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52584-269 | Diprivan | Diprivan |
| 63323-269 | Diprivan | PROPOFOL |
| 65219-800 | Diprivan | PROPOFOL |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DIPRIVAN 73441920 1304645 Live/Registered |
Imperial Chemical Industries PLC 1983-09-01 |